Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06623162
Title Sasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer Patients (SASAN-SPARING)
Acronym SASAN-SPARING
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion de investigacion HM
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.